Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys
Running, not enrolling
Conditions studied: Kidney Transplantation in Highly Sensitized Patients
In brief
The goal of this follow-up study is to learn about long-term patient survival and graft function in highly sensitized patients who have received desensitization treatment with imlifidase or standard of care (SoC) in order to enable kidney transplantation in clinical study ConfIdeS (20-HMedIdeS-17, NCT04935177).
Key facts
- Study ID
- NCT05714514
- Run by
- Hansa Biopharma AB
- People needed
- 64
- Starts
- 2023-04-21
- Expected to finish
- 2029-12-31
- Last updated by the study team
- 2025-11-18
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Signed Informed Consent obtained before any trial-related procedures.
- Previous participation in the clinical trial ConfIdeS.
You may not qualify if…
- Inability by the judgement of the investigator to participate in the trial for any reason.
Where it is running
- University of Alabama at Birmingham (UAB) Hospital — Birmingham, Alabama, United States
- Cedars-Sinai Medical Center — Los Angeles, California, United States
- Northwestern University, Dept. General Surgery, Div. Transplantation — Chicago, Illinois, United States
- University of Chicago, Department of Surgery, Clinical Research Center — Chicago, Illinois, United States
- John Hopkins Hospital — Baltimore, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Cooperman Barnabas Medical Center — Livingston, New Jersey, United States
- New York University (NYU) Langone Transplant Institute, NYU Langone Health — New York, New York, United States
- Columbia University — New York, New York, United States
- Houston Methodist Hospital — Houston, Texas, United States
- Methodist Hospital Specialty and Transplant — San Antonio, Texas, United States
- University of Washington Medical Center — Seattle, Washington, United States
- Medical College of Wisconsin — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.